SPEAR Trademark

Trademark Overview


On Monday, August 15, 2016, a trademark application was filed for SPEAR with the United States Patent and Trademark Office. The USPTO has given the SPEAR trademark a serial number of 79196792. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 1, 2017. This trademark is owned by Adaptimmune Limited. The SPEAR trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; immunotherapy preparations for the treatment of cancer and autoimmune diseases; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors

Medical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient
spear

General Information


Serial Number79196792
Word MarkSPEAR
Filing DateMonday, August 15, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 1, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune diseases; immunotherapy preparations for the treatment of cancer and autoimmune diseases; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
Goods and ServicesMedical treatment services, namely, administration of gene therapy to patients involving harvesting a patient's white blood cells, transducing or combining white blood cells with gene encoding T-cell receptor and re-administration of white blood cells to patient; Medical and therapeutic services, namely immunotherapy services comprising harvesting a patient's white blood cells, transducing the white blood cells with the gene encoding the engineered T-cell receptor and re-administration of the transduced white blood cells back into the patient

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 29, 2016
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptimmune Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 16, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 1, 2018FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 1, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 11, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, November 2, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, November 1, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, November 1, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, April 5, 2017FINAL REFUSAL MAILED
Tuesday, April 4, 2017FINAL REFUSAL WRITTEN
Tuesday, March 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 17, 2016REFUSAL PROCESSED BY IB
Saturday, December 3, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, November 30, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 30, 2016REFUSAL PROCESSED BY MPU
Wednesday, November 30, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 29, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2016ASSIGNED TO EXAMINER
Tuesday, November 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 24, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB